![Pratik Shah](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 42 M $ al 31/05/2026
Pratik Shah is the founder of Design Therapeutics, Inc., founded in 2017, holding the titles of Executive Chairman, President, CEO & CFO since 2023.
Dr. Shah is also the founder of Kalypsys, Inc.,NephRx Corp...
Dr. Shah currently serves as Chairman at ARS Pharmaceuticals Operations, Inc. since 2018, Chairman at ARS Pharmaceuticals, Inc. since 2022, Trustee at UC San Diego Foundation, and President at Marlinspike Group LLC since 2018.
Former positions include President & Co-Chief Executive Officer at Auspex Pharmaceuticals, Inc. from 2013 to 2015, President & Chief Executive Officer at Marlinspike Group, Inc. from 2015 to 2020, Chairman at Synthorx, Inc. from 2018 to 2022, Director at CNS Therapeutics, Inc., Non-Executive Director at Cebix, Inc., Independent Director at OCERA Therapeutics LLC from 2005 to 2014, Director at Super Green Biofuels, Inc., Principal at McKinsey & Co., Inc., and Partner at Thomas, McNerney & Partners LLC from 2004 to 2014.
Education includes an MBA and doctorate from The University of Chicago and an undergraduate degree from the University of California, Irvine.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 24/06/2026 | 4.474.554 ( 4,51 % ) | 41 M $ | 31/05/2026 | |
| 31/03/2026 | 129.923 ( 0,21 % ) | 1 M $ | 31/05/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| DESIGN THERAPEUTICS, INC. | Director Ejecutivo | 25/08/2023 |
| ARS PHARMACEUTICALS, INC. | Presidente | 08/11/2022 |
Marlinspike Group LLC | Presidente | 01/08/2018 |
UC San Diego Foundation
 UC San Diego Foundation Investment Trusts/Mutual FundsMiscellaneous Operates foundation | Director/Miembro de la Junta | - |
ARS Subsidiary, Inc.
 ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Presidente | 01/09/2018 |
| Empresas | Cargo | Fin |
|---|---|---|
| SYNTHORX, INC. | Presidente | 01/02/2022 |
Marlinspike Group, Inc. | Director Ejecutivo | 01/10/2020 |
| AUSPEX PHARMACEUTICALS INC | Director Ejecutivo | 01/05/2015 |
| OCERA THERAPEUTICS INC | Director/Miembro de la Junta | 18/02/2014 |
| ░░░░░░░ ░░░░░░░░ ░░░░░ ░░░░░░░░ ░░░ | ░░░░░░░░ ░░ ░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 18 |
|---|---|
Kalypsys, Inc.
 Kalypsys, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel, first-in-class therapeutic agents to address unmet medical needs in respiratory and inflammatory diseases | Health Technology |
NephRx Corp.
 NephRx Corp. BiotechnologyHealth Technology Provides therapeutic products for the treatment of kidney failure | Health Technology |
CNS Therapeutics, Inc.
 CNS Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops and manufactures drug delivery products | Health Technology |
Cebix, Inc.
 Cebix, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for complications of diabetes | Health Technology |
McKinsey & Co., Inc.
 McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services Operates as a management consulting firm | Commercial Services |
OCERA Therapeutics LLC
 OCERA Therapeutics LLC Pharmaceuticals: MajorHealth Technology Manufactures pharmaceuticals products | Health Technology |
The University of Chicago
 The University of Chicago Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of California, Irvine
 University of California, Irvine Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Thomas, McNerney & Partners LLC
 Thomas, McNerney & Partners LLC Investment ManagersFinance TMT invests in companies located in the United States. The firm targets companies operating in the fields of life sciences and medical technology. It participates in restructuring transactions including spin-outs, roll ups and recapitalizations with an investment size of USD 5 - 40 million. | Finance |
Auspex Pharmaceuticals, Inc.
 Auspex Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company | Health Technology |
Super Green Biofuels, Inc.
 Super Green Biofuels, Inc. BiotechnologyHealth Technology Develops and markets hybrid crop breeding solutions | Health Technology |
Synthorx, Inc.
 Synthorx, Inc. BiotechnologyHealth Technology Operates as a biotechnology company that uses synthetic biology to discover and develop protein therapeutics | Health Technology |
ARS Subsidiary, Inc.
ARS Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology Develops epinephrine nasal sprays for treatment of severe allergic reactions | Health Technology |
UC San Diego Foundation
UC San Diego Foundation Investment Trusts/Mutual FundsMiscellaneous Operates foundation | Miscellaneous |
Design Therapeutics, Inc.
 Design Therapeutics, Inc. BiotechnologyHealth Technology Operates biotechnology company that develops therapies for serious degenerative disorders | Health Technology |
Marlinspike Group, Inc. | |
Marlinspike Group LLC | |
ARS Pharmaceuticals, Inc.
 ARS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops pharmaceuticals | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
Elige MarketScreener 
